Welcome to Glycodisplay.com - Improving biologics by modifying glycans

+45 42703088
info@glycodisplay.com

Home
Glycodisplay Technology
- Glycodisplay Platform
- Optimizing biologics
Partnering and Investors
- Partnering
- Investors
Media and publications
- News
- Publications by GlycoDisplay scientists
About us
- Team

Contact us

Contact us Today

Fill up the Contact Form.

Name *

Email *

Phone *

Message *

Article

Glycodisplay
Nyheder
New publication from GlycoDisplay scientists

Subpages

News
Publications by GlycoDisplay scientists

Media & Publications

Bioprocessing Summit in Boston

* New Publication on GlycoDisplay Technology

Nature Communications publication

Innovation Fund Denmark grant industrial PostDoc to GlycoDisplay

New publication from GlycoDisplay scientists

01. dec 2017

New publication on targeted gene-editing, demonstrating GlycoDisplay's commitment to continous optimization of technologies.

Link: http://www.sciencedirect.com/science/article/pii/S1877117317301370?via%3Dihub

About GlycoDisplay.com

GlycoDisplay develops novel biopharmaceuticals by modifying sugars. The proprietary technology applies targeted cell engineering to display different glycans on cells and proteins. GlycoDisplay is a spin-out from University of Copenhagen, Center for Glycomics, which is world leading within the field of glyco-engineering and glycomics.

Links

Home
Glycodisplay Technology
Partnering and Investors
Media and publications
About us

Contact

CONTACT US HERE

Call Us Anytime
+45 42703088
Email Us At
info@glycodisplay.com

Toy illustration by Lise Grastrup